首页> 外文OA文献 >Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis
【2h】

Chitosan nanoparticles loaded with the antimicrobial peptide temporin B exert a long-term antibacterial activity in vitro against clinical isolates of Staphylococcus epidermidis

机译:负载抗菌肽temporin B的壳聚糖纳米颗粒在体外对表皮葡萄球菌临床分离株具有长期抗菌活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nowadays, the alarming rise in multidrug-resistant microorganisms urgently demands for suitable alternatives to current antibiotics. In this regard, antimicrobial peptides (AMPs) have received growing interest due to their broad spectrum of activities, potent antimicrobial properties, unique mechanisms of action, and low tendency to induce resistance. However, their pharmaceutical development is hampered by potential toxicity, relatively low stability and manufacturing costs. In the present study, we tested the hypothesis that the encapsulation of the frog-skin derived AMP temporin B (TB) into chitosan nanoparticles (CS-NPs) could increase peptide's antibacterial activity, while reducing its toxic potential. TB-loaded CS-NPs with good dimensional features were prepared, based on the ionotropic gelation between CS and sodium tripolyphosphate. The encapsulation efficiency of TB in the formulation was up to 75%. Release kinetic studies highlighted a linear release of the peptide from the nanocarrier, in the adopted experimental conditions. Interestingly, the encapsulation of TB in CS-NPs demonstrated to reduce significantly the peptide's cytotoxicity against mammalian cells. Additionally, the nanocarrier evidenced a sustained antibacterial action against various strains of Staphylococcus epidermidis for at least 4 days, with up to 4-log reduction in the number of viable bacteria compared to plain CS-NPs at the end of the observational period. Of note, the antimicrobial evaluation tests demonstrated that while the intrinsic antimicrobial activity of CS ensured a "burst" effect, the gradual release of TB further reduced the viable bacterial count, preventing the regrowth of the residual cells and ensuring a long-lasting antibacterial effect. The developed nanocarrier is eligible for the administration of several AMPs of therapeutic interest with physical-chemical characteristics analog to those of TB.
机译:如今,耐多药微生物的惊人增长迫切需要替代当前抗生素的合适替代品。在这方面,由于抗菌肽(AMPs)的广谱活性,有效的抗菌特性,独特的作用机制以及诱导耐药性的趋势较低,因此受到越来越多的关注。但是,它们的药物开发受到潜在毒性,相对较低的稳定性和制造成本的阻碍。在本研究中,我们测试了以下假设:将蛙皮来源的AMP temporin B(TB)封装到壳聚糖纳米颗粒(CS-NPs)中可以增加肽的抗菌活性,同时降低其毒性潜力。基于CS和三聚磷酸钠之间的离子凝胶作用,制备了具有良好尺寸特征的TB负载CS-NP。 TB在制剂中的包封率高达75%。释放动力学研究强调了在采用的实验条件下肽从纳米载体的线性释放。有趣的是,在CS-NP中封装TB可以显着降低该肽对哺乳动物细胞的细胞毒性。另外,纳米载体被证明对表皮葡萄球菌的各种菌株具有持续的抗菌作用至少4天,与普通CS-NP在观察期结束时相比,存活细菌的数量最多减少了4个对数。值得注意的是,抗菌评估测试表明,尽管CS的固有抗菌活性确保了“爆发”效果,但TB的逐步释放进一步减少了活菌数量,防止了残留细胞的再生,并确保了持久的抗菌作用。 。所开发的纳米载体适合于施用具有与结核病类似的理化特性的几种具有治疗意义的AMP。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号